Biostar Pharmaceuticals, Inc. (BSPM)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
Biostar Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '17 Sep 30, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
| Net Income | 0.93 | -5.7 | -25.11 | 4.85 | 0.81 | -20 | Upgrade
|
| Depreciation & Amortization | 1.11 | 1.14 | 2.32 | 3.09 | 2.79 | 1.83 | Upgrade
|
| Other Amortization | - | - | 1.07 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.74 | -1.09 | -1.17 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 6.99 | 5.38 | 3.47 | 4.48 | Upgrade
|
| Stock-Based Compensation | - | - | - | 2.02 | 0.76 | 0.82 | Upgrade
|
| Provision & Write-off of Bad Debts | -8.09 | -0.27 | 4.67 | - | -1.29 | 3.67 | Upgrade
|
| Other Operating Activities | 2.18 | 2.43 | 1.01 | -4.86 | 1.31 | -0.69 | Upgrade
|
| Change in Accounts Receivable | 13.94 | 8.67 | 5.45 | -7.44 | 4.2 | 6.63 | Upgrade
|
| Change in Inventory | 0.27 | 0.06 | 0.42 | 0.15 | 0.04 | 0.54 | Upgrade
|
| Change in Accounts Payable | -1.41 | -1.09 | -0.6 | 0.57 | -1.45 | 3.2 | Upgrade
|
| Change in Income Taxes | - | - | - | 0.31 | -0.1 | -1.92 | Upgrade
|
| Change in Other Net Operating Assets | -0.36 | -0.33 | 0.08 | 0.33 | -0.46 | -2.14 | Upgrade
|
| Operating Cash Flow | 8.59 | 4.91 | 5.88 | 3.31 | 8.91 | -3.58 | Upgrade
|
| Operating Cash Flow Growth | 22.76% | -16.41% | 77.53% | -62.84% | - | - | Upgrade
|
| Capital Expenditures | - | - | -0.06 | -2.87 | -0.98 | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0 | - | 0.02 | Upgrade
|
| Cash Acquisitions | -10.79 | -6.38 | -8.12 | -4.88 | -3.87 | -0.82 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -1.13 | 0.65 | -6.95 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | -9.51 | Upgrade
|
| Investing Cash Flow | -10.79 | -6.38 | -7.38 | -8.88 | -4.21 | -17.29 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 3.25 | - | 6.34 | Upgrade
|
| Total Debt Issued | - | - | - | 3.25 | - | 6.34 | Upgrade
|
| Short-Term Debt Repaid | - | -0.28 | -0.16 | -0.16 | -6.46 | -0.79 | Upgrade
|
| Total Debt Repaid | 0 | -0.28 | -0.16 | -0.16 | -6.46 | -0.79 | Upgrade
|
| Net Debt Issued (Repaid) | 0 | -0.28 | -0.16 | 3.09 | -6.46 | 5.55 | Upgrade
|
| Issuance of Common Stock | 1.07 | 1.07 | - | 2.9 | - | - | Upgrade
|
| Other Financing Activities | 0.62 | 0.62 | - | 0.96 | - | - | Upgrade
|
| Financing Cash Flow | 1.69 | 1.41 | -0.16 | 6.95 | -6.46 | 5.55 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.21 | 0.19 | 0.01 | 0.22 | 0.08 | 0.11 | Upgrade
|
| Net Cash Flow | -0.29 | 0.13 | -1.65 | 1.61 | -1.68 | -15.21 | Upgrade
|
| Free Cash Flow | 8.59 | 4.91 | 5.82 | 0.44 | 7.93 | -3.62 | Upgrade
|
| Free Cash Flow Growth | 23.27% | -15.56% | 1217.98% | -94.43% | - | - | Upgrade
|
| Free Cash Flow Margin | 2702.11% | 206.03% | 21.44% | 0.72% | 15.03% | -7.33% | Upgrade
|
| Free Cash Flow Per Share | 3.28 | 2.14 | 2.63 | 0.21 | 4.82 | -2.65 | Upgrade
|
| Cash Interest Paid | - | 0.04 | 0.13 | 0.15 | 0.36 | 0.06 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.67 | 0.97 | 2.39 | Upgrade
|
| Levered Free Cash Flow | 7.47 | 6.69 | 20.68 | -3.19 | 6.18 | -8.16 | Upgrade
|
| Unlevered Free Cash Flow | 7.59 | 6.82 | 20.86 | -3.09 | 6.41 | -8.11 | Upgrade
|
| Change in Net Working Capital | -4.74 | -7.91 | -24.33 | 5.02 | -2.74 | -3.81 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.